Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Benign Prostatic Hyperplasia Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Benign Prostatic Hyperplasia Testingmarket, defines the market attractiveness level of Benign Prostatic Hyperplasia Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Benign Prostatic Hyperplasia Testing industry, describes the types of Benign Prostatic Hyperplasia Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Benign Prostatic Hyperplasia Testing market and the development prospects and opportunities of Benign Prostatic Hyperplasia Testing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Benign Prostatic Hyperplasia Testing market in Chapter 13.
By Player:
Astellas Pharma
Protox Therapeutics
IntelGenx Technologies Corp
Nymox Pharmaceutical Corporation
Quest PharmaTech
Eli Lilly and Company
AEternaZentaris
By Type:
Urinalysis
Prostate-Specific Antigen (PSA) Blood Test
Urodynamic Test
Cystoscopy
By End-User:
Hospitals
Diagnostic Centers
Clinics
Research Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Benign Prostatic Hyperplasia Testing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Benign Prostatic Hyperplasia Testing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Benign Prostatic Hyperplasia Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Benign Prostatic Hyperplasia Testing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Benign Prostatic Hyperplasia Testing Market Analysis and Outlook to 2022
-
7.1 Global Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
-
7.2 United States Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
-
7.3 Europe Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
-
7.4 China Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
-
7.5 Japan Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
-
7.6 India Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
-
7.7 South Korea Benign Prostatic Hyperplasia Testing Consumption (2017-2022)
8 Region and Country-wise Benign Prostatic Hyperplasia Testing Market Analysis and Outlook to 2028
-
8.1 Global Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
-
8.2 United States Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
-
8.3 Europe Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
-
8.4 China Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
-
8.5 Japan Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
-
8.6 India Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
-
8.7 South Korea Benign Prostatic Hyperplasia Testing Consumption Forecast (2022-2028)
9 Global Benign Prostatic Hyperplasia Testing Market Outlook by Types and Applications to 2022
-
9.1 Global Benign Prostatic Hyperplasia Testing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Urinalysis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prostate-Specific Antigen (PSA) Blood Test Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Urodynamic Test Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cystoscopy Consumption and Growth Rate (2017-2022)
-
9.2 Global Benign Prostatic Hyperplasia Testing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Global Benign Prostatic Hyperplasia Testing Market Outlook by Types and Applications to 2028
-
10.1 Global Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Urinalysis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prostate-Specific Antigen (PSA) Blood Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Urodynamic Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cystoscopy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Benign Prostatic Hyperplasia Testing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Benign Prostatic Hyperplasia Testing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Benign Prostatic Hyperplasia Testing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Benign Prostatic Hyperplasia Testing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Benign Prostatic Hyperplasia Testing Market Competitive Analysis
-
14.1 Astellas Pharma
-
14.1.1 Astellas Pharma Company Details
-
14.1.2 Astellas Pharma Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Pharma Benign Prostatic Hyperplasia Testing Product and Service
-
14.2 Protox Therapeutics
-
14.2.1 Protox Therapeutics Company Details
-
14.2.2 Protox Therapeutics Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Protox Therapeutics Benign Prostatic Hyperplasia Testing Product and Service
-
14.3 IntelGenx Technologies Corp
-
14.3.1 IntelGenx Technologies Corp Company Details
-
14.3.2 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Product and Service
-
14.4 Nymox Pharmaceutical Corporation
-
14.4.1 Nymox Pharmaceutical Corporation Company Details
-
14.4.2 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Product and Service
-
14.5 Quest PharmaTech
-
14.5.1 Quest PharmaTech Company Details
-
14.5.2 Quest PharmaTech Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Quest PharmaTech Benign Prostatic Hyperplasia Testing Product and Service
-
14.6 Eli Lilly and Company
-
14.6.1 Eli Lilly and Company Company Details
-
14.6.2 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Product and Service
-
14.7 AEternaZentaris
-
14.7.1 AEternaZentaris Company Details
-
14.7.2 AEternaZentaris Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AEternaZentaris Benign Prostatic Hyperplasia Testing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Benign Prostatic Hyperplasia Testing
-
Figure Benign Prostatic Hyperplasia Testing Picture
-
Table Global Benign Prostatic Hyperplasia Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Benign Prostatic Hyperplasia Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Benign Prostatic Hyperplasia Testing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Benign Prostatic Hyperplasia Testing Consumption by Country (2017-2022)
-
Figure United States Benign Prostatic Hyperplasia Testing Consumption and Growth Rate (2017-2022)
-
Table Europe Benign Prostatic Hyperplasia Testing Consumption and Growth Rate (2017-2022)
-
Figure China Benign Prostatic Hyperplasia Testing Consumption and Growth Rate (2017-2022)
-
Figure Japan Benign Prostatic Hyperplasia Testing Consumption and Growth Rate (2017-2022)
-
Figure India Benign Prostatic Hyperplasia Testing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Benign Prostatic Hyperplasia Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Benign Prostatic Hyperplasia Testing Consumption Forecast by Country (2022-2028)
-
Figure United States Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Benign Prostatic Hyperplasia Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinalysis Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate-Specific Antigen (PSA) Blood Test Consumption and Growth Rate (2017-2022)
-
Figure Global Urodynamic Test Consumption and Growth Rate (2017-2022)
-
Figure Global Cystoscopy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Urinalysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate-Specific Antigen (PSA) Blood Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urodynamic Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cystoscopy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Benign Prostatic Hyperplasia Testing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Testing Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Benign Prostatic Hyperplasia Testing Product and Service
-
Table Protox Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Protox Therapeutics Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protox Therapeutics Benign Prostatic Hyperplasia Testing Product and Service
-
Table IntelGenx Technologies Corp (Foundation Year, Company Profile and etc.)
-
Table IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Product and Service
-
Table Nymox Pharmaceutical Corporation (Foundation Year, Company Profile and etc.)
-
Table Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Product and Service
-
Table Quest PharmaTech (Foundation Year, Company Profile and etc.)
-
Table Quest PharmaTech Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest PharmaTech Benign Prostatic Hyperplasia Testing Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Benign Prostatic Hyperplasia Testing Product and Service
-
Table AEternaZentaris (Foundation Year, Company Profile and etc.)
-
Table AEternaZentaris Benign Prostatic Hyperplasia Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table AEternaZentaris Benign Prostatic Hyperplasia Testing Product and Service
-
